Adaptive Biotechnologies (FRA:1HM) Other Long Term Assets : €5.7 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies Other Long Term Assets?

Adaptive Biotechnologies's other long-term assets for the quarter that ended in Jun. 2024 was €5.7 Mil.

Adaptive Biotechnologies's quarterly other long-term assets declined from Dec. 2023 (€6.0 Mil) to Mar. 2024 (€5.8 Mil) but then stayed the same from Mar. 2024 (€5.8 Mil) to Jun. 2024 (€5.7 Mil).

Adaptive Biotechnologies's annual other long-term assets increased from Dec. 2021 (€2.7 Mil) to Dec. 2022 (€4.2 Mil) and increased from Dec. 2022 (€4.2 Mil) to Dec. 2023 (€6.0 Mil).

Adaptive Biotechnologies Other Long Term Assets Historical Data

The historical data trend for Adaptive Biotechnologies's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies Other Long Term Assets Chart

Adaptive Biotechnologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

2.63

2.25

2.67

4.21

5.98

Adaptive Biotechnologies Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long Term Assets	Get a 7-Day Free Trial															5.79	5.53	5.98	5.85	5.69

Adaptive Biotechnologies Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Adaptive Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (FRA:1HM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ADPT:USA 1HM:Germany

Address

1165 Eastlake Avenue East, Seattle, WA, USA, 98109

Website

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Adaptive Biotechnologies Headlines

No Headlines